Clinical Trials Directory

Trials / Conditions / Doxorubicin Induced Cardiomyopathy

Doxorubicin Induced Cardiomyopathy

9 registered clinical trials studyying Doxorubicin Induced Cardiomyopathy — 2 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingTelmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
NCT07370506
Tanta UniversityPhase 1 / Phase 2
RecruitingEvaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Card
NCT06427226
Tanta UniversityPhase 2
UnknownMitochondrial dysfUnction: a Key Player in Doxorubicin-induced Skeletal and Cardiac muscLE Damage
NCT05731375
UMC Utrecht—
UnknownA Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cance
NCT06092606
Monyan Pharmaceutical (Shanghai) Co., Ltd.Phase 2
UnknownRole of Statin Therapy in Prevention of Anthracycline-Induced Cardiotoxicity
NCT05792293
Ain Shams UniversityPhase 2 / Phase 3
UnknownEvaluation of Myocardial Injury After Anthracycline Chemotherapy in Osteosarcoma Patients Using CMR
NCT04461223
Second Affiliated Hospital, School of Medicine, Zhejiang University—
Terminated99mTc-rhAnnexin V-128 Imaging and Cardiotoxicity in Patients With Early Breast Cancer
NCT02677714
Advanced Accelerator ApplicationsPhase 2
CompletedPrevention Using Exercise Rehabilitation to Offset Cardiac Toxicities Induced Via Chemotherapy
NCT02796365
Henry Ford Health SystemN/A
CompletedDoxorubicin-associated Cardiac Remodeling Followed by CMR in Breast Cancer Patients
NCT03000036
University of Campinas, BrazilN/A